People: Nektar Therapeutics (NKTR.O)

NKTR.O on Nasdaq

10.99USD
11:56am EDT
Price Change (% chg)

$-0.03 (-0.27%)
Prev Close
$11.02
Open
$11.13
Day's High
$11.22
Day's Low
$10.95
Volume
484,311
Avg. Vol
1,127,015
52-wk High
$15.34
52-wk Low
$8.87

Search Stocks

Robin, Howard 

Brief Biography

Mr. Howard W. Robin is President, Chief Executive Officer, Director of Nektar Therapeutics. He has served as President and Chief Executive Officer since January 2007 and has served as a member of our board of directors since February 2007. Mr. Robin served as Chief Executive Officer, President and a director of Sirna Therapeutics, Inc., a biotechnology company, from July 2001 to November 2006 and from January 2001 to June 2001, served as their Chief Operating Officer, President and as director. From 1991 to 2001, Mr. Robin was Corporate Vice President and General Manager at Berlex Laboratories, Inc., a pharmaceutical products company that is a subsidiary of Schering, AG, and from 1987 to 1991 he served as Vice President of Finance and Business Development and Chief Financial Officer. From 1984 to 1987, Mr. Robin was Director of Business Planning and Development at Berlex. He was a Senior Associate with Arthur Andersen & Co. prior to joining Berlex. He received his B.S. in Accounting and Finance from Fairleigh Dickinson University in 1974.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,487,450 -- 2,082,200 3,569,650

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Chess

1,468,750

Howard Robin

3,569,650

John Nicholson

1,662,210

Jillian Thomsen

--

Stephen Doberstein

1,159,600

Gil Labrucherie

1,478,490
As Of 30 Dec 2013
Search Stocks